Company
e-Therapeutics PLC
LON:ETX
e-Therapeutics PLC is integrating computational power and biology to accelerate the discovery of life-transforming RNAi medicines. The company has developed and validated a powerful computational approach to drug discovery, leveraging our industry-leading expertise in network biology to fully capture and interrogate human disease complexity. e-Therapeutics' multi-disciplinary team builds computational models of biological functions to transform the search for new medicines, interventions, mechanisms and genetic support.
153 stories · page 1 of 2
e-therapeutics raises £13.5mln via a direct subscription by funds run by M&G
The cash influx will be used to supercharge the development of its gene silencing technology
e-Therapeutics files eight more patents for its gene silencing technology
The patent applications relate to innovation coming from the company’s work on its pre-clinical siRNA candidates
e-Therapeutics hails 'significantly strengthened' cash position as it looks to kick on after a successful year
The company is a specialist in computational drug discovery and gene silencing
e-therapeutics achieves milestone in Galapagos collaboration
“In keeping with previous e-therapeutics projects, the hit rate in the identification of active compounds was several orders of magnitude higher than the industry standard, further validating e-therapeutics' robust computational biology met
Archive
Small Cap Wrap - E-Therapeutics, Faron Pharma, Ondine Biomedical, and more...
5th April 2022*A corporate client of Hybridan LLPDish of the dayJoiners:LSE:ADVT has been readmitted to the Main Market following the reverse takeover of M&C Saatchi.Leavers:Simigon and Clinigen have left AIM.What’s cooking in the IPO kitch
e-therapeutics teams up with US group iTeos Therapeutics to discover potential new cancer treatments
The Oxford-based group will receive undisclosed but material upfront and near-term cash payments as a result of the tie-up
Proactive news headlines: e-Therapeutics, Franchise Brands, MGC Pharmaceuticals...
A round-up of some of the day's highlights from the Proactive Investors newswire
e-Therapeutics eyes industry partnerships following the successful testing of its technology
A separate results statement revealed the company was in a financially strong position to build on this progress
e-Therapeutics unveils new patent filings
The patents are related to the firm's RNAi platform technology for liver gene silencing
e-therapeutics to make US debut on OTCQX Best Market today
Chief executive Ali Mortazavi said: “US institutional and retail investors will now be able to buy and sell our shares via online trading platforms and mobile apps"
Archive
Proactive headlines: e-therapeutics, ZAIM Credit Systems, I3 Energy…
A look at some of today's major headlines from the Proactive newswire
E-therapeutics triggers Galapagos milestone payment
Signed just over a year ago, the objective of the agreement is to find a new drug approach to idiopathic pulmonary fibrosis “and other fibrotic indications”
E-therapeutics appoints head of intellectual property
Alison Gallafent brings with her 20 years of experience as a patent lawyer
Archive
Proactive news headlines: Alpha Financial Markets, Induction Healthcare, Grow Group, Emmerson...
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news headlines: Mailbox REIT, Momentum Multi-Asset Value, CentralNic, SourceBio International...
A glance at some of the day's highlights from the Proactive Investor's newswire
e-Therapeutics raises £22.5mln in equity raise as it aims to expand RNAi capabilities
"I am excited by the potential of e-Therapeutics' proprietary platform technologies to meaningfully transform and accelerate the drug discovery process," said Ali Mortazavi
E-therapeutics aims for more deals and collaborations after expansion into RNAi
“We have begun to build momentum as we move forward with our strategy delivering scientific progress as well as current and prospective partnerships,” said boss Ali Mortazavi
e-therapeutics reaches two key milestones in Galapagos collaboration
“The progress made to date in our collaboration with Galapagos to discover novel therapeutics in IPF and fibrosis is yet another validation of our technology platform," said chief executive Ali Mortazavi
E-therapeutics appoints pharma veteran as CFO
Since 2009, Karl Keegan has held senior executive roles in private and public companies
e-Therapeutics splits chief executive and executive chairman roles
New chairman Trevor Jones was R&D director of The Wellcome Foundation from 1987 to 1994, and a director of Allergan from 2005 to 2015
e-therapeutics seeks patent for liver gene silencing technology
“Our platform has the significant and added advantage of being able to leverage our expertise in network biology," said chairman Ali Mortazavi
e-Therapeutics unveils results of testing of compounds for potential coronavirus treatment
The company said testing from its network-driven drug discovery platform has revealed that inhibition of the same target, GRP94, is effective at suppressing hyperinflammation and also disrupting the ability of the COVID-19 virus to replicat
e-Therapeutics files more patents for its gene silencing technology
Danish giant Novo Nordisk recently signed up to use its NDD platform, and bosses expect more collaboration deals in the coming months
e-therapeutics re-energised as executive chairman Mortazavi takes over CEO duties
"Since his appointment in February, Ali has re-energised the company and, importantly, played a significant role in restructuring the portfolio," said non-executive director, Professor Trevor Jones
e-Therapeutics expands scientific advisory board
The biopharmaceutical firm has appointed Bill Harte, chief translational officer at the Case Western Reserve University School of Medicine in Ohio, and John Mattick, a professor of RNA Biology at UNSW Sydney in Australia
e-Therapeutics unveils fundraising plans to enable next stage of growth
The company is aiming to raise the cash through a combination of a placing, a subscription and a retail offer to investors
e-therapeutics teams up with Belgian life sciences giant Galapagos to tackle fibrosis
The work, which will lean into ETX’s expertise in network biology and in silico phenotypic screening, will focus on approaches to modulate one specific mechanism involved in IPF and other fibrotic conditions
e-therapeutics plotting move into RNA interference; appoints industry big hitter to head scientific advisory board
The R&D specialist believes its computational approach to drug discovery could aid the search for new RNAi drug candidates
e-Therapeutics surges as it begins experimental testing of coronavirus treatment compounds
The firm believes the initial compound set has the potential to address both viral replication and the associated excessive immune response caused by the pathogen
e-therapeutics appoints former Silence Therapeutics executive as its chief business officer
Dr Laura Roca-Alonso held positions of increasing responsibility at Silence Therapeutics until 2019, culminating in her role as VP, Head of Corporate Development
e-therapeutics offers up its rapid screening technology in quest to find COVID-19 vaccine
Its “in silico”, or computer simulation platform has successfully found active compounds capable of protecting human cells in influenza
e-therapeutics "at an important inflexion point"
The COVID-19 pandemic is not expected to materially alter the assumptions included in the group's budget
Former Silence boss takes over at e-Therapeutics in board overhaul; launches £1.6mln placing
Mortazavi will take up the role of executive chairman with Michael Bretherton joining as new independent non-executive
E-Therapeutics making good progress says chief executive
In August, it also announced a collaboration with an unnamed pharma major for a project looking at brain conditions
e-therapeutics teams up with a top-five pharma company for neurodegenerative diseases project
The 12-month tie-up with the unnamed drug giant will showcase the research group's network-driven drug discovery approach
Archive
Proactive news snapshot: Digitalbox, Seeing Machines, Alba Minerals Resources...
A glance at some of the day's highlights from the Proactive Investors newswire
New tool from e-Therapeutics will analyse genomics of type-2 diabetes patients to find new drugs
A new contract extends last December's agreement with Novo Nordisk for another six months to June 2020
Archive
Small cap movers: Junior miners cash in on gold price spike
A look back at some of this week's more interesting stories from London's junior market
Archive
Proactive news snapshot: Thor Mining, Kibo Energy, Minds + Machines Group, Xtract Resources ...
A glance at some of the day's highlights from the Proactive Investors newswire
e-Therapeutics eyes further partnerships and possibly M&A to fully exploit its potential
Its most significant landmark of the year just gone was a collaboration with Danish multi-national Novo Nordisk focusing on type-2 diabetes
Investments and investor services
FTSE 100 closes higher despite lack of catalysts
Footsie finished up around 49 points at 7,183, while the FTSE 250 finished up nearly 32 points at 19,443
Archive
Direct Line to report higher 2018 profits despite large weather-related claims
The day ahead includes full year results from Direct Line and GVC along with a trading update from Ashtead
Archive
Insurance will be the corporate key in coming week, though US jobs data should be biggest draw
The Week Ahead brings updates from the likes of Aviva, Direct Line, L&G and Admiral, while investors can also bet on Paddy Power Betfair and GVC Holdings
Archive
Proactive news snapshot: Avacta, ValiRx, Minds + Machines Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Pressure Technologies steps on the gas after agreeing to sell its alternative energy division
A look at the day's major movers, including Local Shopping REIT, Just Group, Photo-Me, Lb-Shell, Avacta and ValiRx
Danish drugs giant Novo Nordisk to use e-Therapeutics’ technology in search for new diabetes treatments
e-Therapeutics will be reimbursed for its work under this collaboration and Novo Nordisk has the option to license relevant IP generated under the collaboration
Investments and investor services
FTSE 100 closes lower as UK Prime Minister pulls plug on key Brexit vote
The UK premier index finished down around 56 points at 6,721 on Monday
Archive
Proactive news snapshot: Strategic Minerals, Kodal Minerals, e-Therapeutics, Ceres Power …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Boku Inc sinks as it buys loss-making company
A look at the day's major movers, including Metals Exploration, Strategic Minerals, Challenger Acquisitions, Gresham Technologies and Countrywide
e-Therapeutics and C4x Discovery team up to find new Parkinson’s treatments
By combining both of their technologies, the companies think they can identify better treatments for Parkinson’s disease
Archive
FTSE 100 has worst day in over two years as Huawei CFO arrest sends shockwaves through markets
Footsie closed down 217 points today to 6,704, with 7,000 now seemingly a distant memory. .
Hammerson shares decline, while ITM Power's stock gains ground
A look at some winners and losers in the UK equity market on Thursday
Archive
Proactive news snapshot: Haydale Graphene, OptiBiotix Health, Ariana Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
FTSE 100 closes higher but Wall Street lags
The FTSE 250 index, though, fell around 30 points to 18,609 on the day
Archive
Proactive news snapshot: Sirius Minerals, MaxCyte, Arix Bioscience...
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Aminex, E-Therapeutics, Metminco, Mosman Oil & Gas
A glance at some of the day's highlights from the Proactive Investors newswire
E-therapeutics loss narrows in half year as it files new patent for drug discovery platform
The biotech and pharmaceuticals firm reported a pre-tax loss of £2.7mln for the period, almost £1mln less than the £3.6mln loss reported a year ago
Investments and investor services
FTSE 100 closes firmly lower as trade fears, bond yields and sterling rise creates perfect storm
The Footsie closed down nearly 92 points at 7,418, while the other major European benchmarks were also lower.
Investments and investor services
DFS Furniture set to release full year results, have investors already heard the worst?
DFS and Electrocomponents are set to be among Thursday's highlights.
Archive
Jack’s store roll-out in focus as Tesco reports first half results
The week ahead includes Tesco interims, full-year earnings from DFS Furniture and Ferguson, an Electrocomponents trading update and the US non-farm payrolls report
Investments and investor services
Small cap movers: There's gold in them thar hills - but it's hard to get it out
This week's round-up looks at the unforgiving nature of the investing public
Archive
Proactive news snapshot: OptiBiotix Health, Kromek Group, Union Jack Oil …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Cora Gold leads small cap risers as it boasts “exciting high grade results”
A look at some of the biggest risers and fallers in London on Tuesday.
e-Therapeutics and C4X Discovery to collaborate on Parkinson's Disease treatment
The collaboration will see e-Therapeutics combine its Network-Driven Drug Discovery (NDD) platform with C4XD's Taxonomy3 technology
Investments and investor services
FTSE 100 calls Mayday but manages to end the day safely in positive territory
Poor manufacturing stats raise worries over the British economy, the PMI measure for April was the lowest for 17-months..
e-therapeutics sees biopharma sector get in tune with its way of thinking
E-therapeutics believes it is now focused on the right activities
Archive
Proactive news snapshot: Falcon Oil & Gas, ITM Power, OptiBiotix Health …
A glance at some of the day's highlights from the Proactive Investors newswire
Elecosoft shares rise as dividend hiked in full-year results
A look at some of the biggest risers and fallers in London on Tuesday
e-therapeutics sees full-year operating loss significantly reduced as turnaround continues under new CEO
Ray Barlow, who joined as e-therapeutics CEO on 6 April 2017 commented: "During the course of the year, we have continued the turnaround of the business. We are now focused on the right activities"
FTSE 100 stages rebound as trade war fears ease
In the currency markets, the pound shed 0.17% against the Euro, and lost 0.46% against the US dollar
Archive
Ferguson's organic growth rates are likely to be the main points of interest
Also previewed: Irn-Bru maker AG Barr and water company United Utilities
Archive
Utilities dominate week ahead with updates from Pennon, United Utilities and SSE
The week ahead includes trading updates from Pennon, United Utilities and SSE, along with interims from DFS Furniture and full year results from Moss Bros and AG Barr
Archive
Proactive news snapshot: Directa Plus, Harvest Minerals, Greatland Gold
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Shell's investment offshore Scotland bodes well for Hurricane Energy as it advances the Lancaster field
A look at some of the top risers and fallers in London today
e-Therapeutics enhances its AI technology capabilities as it signs two collaboration deals
The tie-ups are with University of Cambridge spin-out Intellegens and Manchester-based Biorelate
FTSE 100 closes lower as Carillion collapses on Blue Monday
The FTSE 100 closed lower. With no Wall Street session there were fewer trading catalysts to turn the tide.
Archive
Proactive news snapshot: ValiRx, PowerHouse Energy, Chaarat Gold …
A glance at some of the day's highlights from the Proactive Investors newswire
One Media IP leaps as former BBC boss Michael Grade invests in the music rights holder
A look at some of the biggest risers and fallers on Monday in London
FTSE 100 closes higher as US tax reform hopes cheer global traders
The UK blue chip index closed up 46.44 points at 7,537
Archive
Proactive news snapshot: Europa Oil & Gas, Cabot Energy, Seeing Machines …
A glance at some of the day's highlights from the Proactive Investors newswire
Seeing Machines shares steer higher as it wins contract with German car manufacturer
A look at some of the biggest risers and fallers in London today
Archive
FTSE 100 closes in red as pound strengthens; BoE in focus
Around 4pm, the UK blue chip index fell 14 points to 7,490 as the Bank of England's interest rate decision looms
Archive
Proactive news snapshot: Victoria Oil & Gas, Eco (Atlantic), Highlands Natural Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
e-Therapeutics sees cash burn and losses fall in first half as new boss’ plans take shape
CEO Ray Barlow only joined the company earlier this year, but he’s already making his mark
FTSE 100 finishes in the red; Tusk says still no progress in Brexit talks
If the 7,300 level were a fence, Footsie would have spent the whole day sitting on it
Archive
Hurricanes paint sombre backdrop to cruise group Carnival 's third quarter
Carnival and Thomas Cook issue trading updates tomorrow with the devastating Caribbean hurricanes likely to be key features of both
Archive
Focus on tour operators TUI and Thomas Cook and utilities in week ahead
Week ahead includes trading updates from tour operators TUI AG and Thomas Cook Group PLC, and numbers from Pennon Group PLC and United Utilities PLC
Archive
Proactive news snapshot - Sphere Medical Holding, Empresaria Group, Sareum Holdings …
A glance at some of the day's highlights from the Proactive Investors newswire
e-Therapeutics pioneering the development of improved new drugs with a focus on cancer
E-Therapeutics’ network-driven drug discovery platform looks at the broader interactions within disease mechanisms